Related references
Note: Only part of the references are listed.Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review
Ernesto Paoletti et al.
JOURNAL OF NEPHROLOGY (2020)
Electrolyte Disorders in Kidney Transplantation
Clifford D. Miles et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study
Arjang Djamali et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Hyperkalemia: pathophysiology, risk factors and consequences
Robert W. Hunter et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Practical recommendations for managing hemolyzed samples in clinical chemistry testing
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice
Luca De Nicola et al.
JOURNAL OF NEPHROLOGY (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment
Claudio Ponticelli et al.
JOURNAL OF NEPHROLOGY (2017)
Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials
Swapnil Hiremath et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Emergency Department Use among Patients with CKD: A Population-Based Analysis
Paul E. Ronksley et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Regression of asymptomatic cardiomyopathy and clinical outcome of renal transplant recipients: a long-term prospective cohort study
Ernesto Paoletti et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial
Greg A. Knoll et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Cardiovascular morbidity and mortality after kidney transplantation
Sokratis Stoumpos et al.
TRANSPLANT INTERNATIONAL (2015)
The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension
Ewout J. Hoorn et al.
NATURE MEDICINE (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Calcineurin Inhibitor Nephrotoxicity
Maarten Naesens et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Mechanisms in Hyperkalemic Renal Tubular Acidosis
Fiona E. Karet
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Timing of Onset of CKD-Related Metabolic Complications
Olivier Moranne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2)
Cristina Esteva-Font et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: A randomized clinical trial
Ernesto Paoletti et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities
R Higgins et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
BF Palmer
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
